Cavitation Technologies Inc's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Cavitation Technologies Inc (CVAT) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Key Findings: Cavitation Technologies Inc vs Its Competitors
- TTM: Trailing 12-month revenue of 0M vs 6M combined for tracked competitors (3.3% combined share).
- Trending: Latest-quarter revenue run-rate is decelerating (-94.2% annualized vs trailing 12 months), vs accelerating (+32.2%) for its tracked peer group.
- Growth: Cavitation Technologies Inc generated -97.5% revenue growth year over year in Q3 2026, vs 42.6% for its tracked competitors combined.
- Profitability: Its -7,300.0% net margin compares with -103.5% for the peer group.
- Scale: Cavitation Technologies Inc ranks #28 of 45 companies by market capitalization in the Agricultural Production industry, holding 0.0% of industry market cap.
- Peer revenue share: Cavitation Technologies Inc accounted for 0.2% of combined revenue among its tracked peer group, down from 8.0% a year earlier.
- Peer differentiation: Revenue per employee of $0.04M compares with $0.19M for the peer group (0.2x).
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
CVAT Sales vs. its Competitors, Q3 2026
Cavitation Technologies Inc reported revenue contraction of 97.54 % year on year in Q3 2026, below its competitors' combined revenue growth of 42.58 %.
With a net margin of -7,300.00 %, Cavitation Technologies Inc reported lower profitability than its competitors (-103.53 %).
Cavitation Technologies Inc generated 0.15 % of the combined sales of its peer group, down from 7.99 % a year earlier.
Cavitation Technologies Inc vs. its Competitors, Q3 2026
Revenue growth, year on year
Net margin
Revenue run-rate vs trailing 12 months
TTM net margin
TTM = trailing twelve months. Run-rate annualizes the latest quarter (×4) and compares it to TTM. In millions of $. High-Confidence Competitors are named as a competitor directly in an SEC filing; Similar-Size Competitors are the closest peers by market-cap rank within the same industry; Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC, all independent of the competitor list.
TTM revenue, latest-quarter run-rate and net income/margin benchmarked across Cavitation Technologies Inc and its 4 competitor groupings. Available under Commercial License.
| Entity | TTM Revenue | Rev Run-rate vs TTM |
|---|---|---|
| Cavitation Technologies Inc | $12,345M | +12.3% · Accelerating |
| Competitors combined | $12,345M | +12.3% · Accelerating |
| High-Confidence Competitors (1) | $12,345M | +12.3% · Accelerating |
| Similar-Size Competitors (7) | $12,345M | +12.3% · Accelerating |
TTM revenue, run-rate and net margin benchmarking across Cavitation Technologies Inc's competitor groups requires a Commercial License.
For context: the Agricultural Production industry grew revenue 16.8% year over year, combined, vs -97.5% for Cavitation Technologies Inc. Cavitation Technologies Inc's share of combined industry revenue moved from 0.00% to 0.00%, a gain of 0.00 percentage points.
Cavitation Technologies Inc's Competitor Quality Breadth
Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).
| Entity | Profitable | Expanding | Above Industry Growth | Distressed |
|---|---|---|---|---|
| Cavitation Technologies Inc | - | - | - | Yes |
| Competitors combined (1) | - | |||
| High-Confidence Competitors (1) | ||||
| Similar-Size Competitors (9) |
Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.
CVAT Stock Performance relative to its Competitors
CVAT Stock Performance relative to High-Confidence Competitors
CVAT Stock Performance relative to Similar-Size Competitors
Cavitation Technologies Inc's Comment on Competition and Industry Peers
Publicly Traded Peers of Cavitation Technologies Inc
Revenue and income for trailing 12 months, in millions of $, except employees| Company | Market Cap | Revenues |
|---|---|---|
| Cavitation Technologies Inc | 12.95 | 0.21 |
| Originclear Inc | 8.09 | 6.06 |
| SUBTOTAL | 21.03 | 6.26 |
Sources: Cavitation Technologies Inc's official press releases and regulatory filings; CSIMarket.com's market research; and the financial filings and press releases of the other companies cited.
Updated on:
Focus of this report: publicly traded companies. Ten additional tables on Cavitation Technologies Inc versus competitors, including market share analysis, are in the navigation menu under Competition. To download the tables, please subscribe.
Cavitation Technologies Inc's Competitors Named by the Company
Competitive relationships identified from SEC filings and corroborating sources, each with a basis and confidence.| Competitor | Basis | Confidence |
|---|---|---|
| Arisdyne Systems | Named by the company | 85% |
| Crown Iron Works | Named by the company | 85% |
| Alfa Laval | Named by the company | 85% |
Filing basis, confidence, active dates and source counts for Cavitation Technologies Inc's named competitors require a Commercial License.
Methodology: relationships are extracted from SEC filings (named-competitor disclosures) and corroborating sources. Named by the company = explicitly disclosed as a competitor; Inferred = derived from corroborating signals. Confidence reflects evidence strength.
Cavitation Technologies Inc's Productivity vs Peers Comparison
Revenue and income per employee, trailing 12 months, in $; market cap in millions of $| Company | Market Cap | Revenue / Employee | Income / Employee |
|---|---|---|---|
| Cavitation Technologies Inc | 13 | 41,200 | -237,600 |
| Originclear Inc | 8 | 189,318 | -443,869 |
| PEERS TOTAL | 8 | 189,318 | -443,869 |
Cavitation Technologies Inc's Position in Industry Market Structure
Market-capitalization share and concentration across all 39 companies in Cavitation Technologies Inc's industry classification, broader than the peer set above. Market cap in millions of $.Cavitation Technologies Inc ranks #28 of 39 companies by market capitalization in its industry, holding 0.01 % of total industry market cap. The industry's Herfindahl-Hirschman Index (HHI) is 1,570, indicating a moderately concentrated market structure (U.S. antitrust guidance: below 1,500 unconcentrated, 1,500 to 2,500 moderately concentrated, above 2,500 highly concentrated).
| Rank | Company | Market Cap | Industry Share |
|---|---|---|---|
| 1 | Archer daniels midland Co | 38,984 | 25.25 % |
| 2 | Nutrien Ltd | 35,020 | 22.69 % |
| 3 | Bunge Global Sa | 21,347 | 13.83 % |
| 4 | Cf Industries Holdings inc | 17,777 | 11.52 % |
| 5 | Darling Ingredients Inc | 1,234 | 5.2% |
| 6 | Mosaic Co | 1,234 | 5.2% |
| 7 | Icl Group Ltd | 1,234 | 5.2% |
| 8 | Seaboard Corporation | 1,234 | 5.2% |
| 9 | Scotts Miracle gro Co | 1,234 | 5.2% |
| 10 | Andersons Inc | 1,234 | 5.2% |
| 28 | Cavitation Technologies Inc | 13 | 0.01 % |
Market cap and industry share for the rest of Cavitation Technologies Inc's industry peers requires a Commercial License.
Source: CSIMarket API (daily market-structure computation) across CSIMarket's industry classification, market capitalization as of 2026-09-28.
Cavitation Technologies Inc's Same-Size Peers & Stock Performance
Peers chosen by closeness in market-cap rank within the same industry classification (not the named-competitor list above). Trailing 12-month total return, 3-month price momentum, beta and Sharpe ratio vs the broad U.S. market.| Rank | Company | Market Cap | TTM Return |
|---|---|---|---|
| 23 | Golden Growers Cooperative | 77 | - |
| 24 | American Vanguard Corporation | 51 | -67.53 % |
| 25 | Rythm Inc | 49 | -41.25 % |
| 26 | Local Bounti Corporation | 30 | -64.38 % |
| 27 | Bioceres Crop Solutions Corp | 1,234 | 12.3% |
| 28 | Cavitation Technologies Inc | 13 | -34.33 % |
| 29 | Australian Oilseeds Holdings Limited | 1,234 | 12.3% |
| 30 | Bion Environmental Technologies Inc | 1,234 | 12.3% |
| 31 | Bloomia Holdings inc | 1,234 | 12.3% |
| 32 | Origin Agritech Limited | 1,234 | 12.3% |
| 33 | Aquabounty Technologies Inc | 1,234 | 12.3% |
Market cap, return, momentum, beta and Sharpe ratio for the rest of Cavitation Technologies Inc's same-size peers requires a Commercial License.
Source: CSIMarket API (daily market-structure computation); returns and risk metrics as of 2026-09-28. Beta and Sharpe ratio are versus the broad U.S. equity market, not this industry.
Cavitation Technologies Inc's Valuation vs Competitive Position
Valuation multiples vs the Agricultural Production industry average (58 companies, excluding loss-making/negative-equity outliers), alongside returns on capital for context on whether a premium or discount lines up with measurably stronger or weaker returns. See the full Agricultural Production industry valuation benchmarks.| Metric | Company | Industry Average | Difference |
|---|---|---|---|
| P/E | - | 20.8x | - |
| EV / EBITDA | - | 9.8x | - |
| P/B | -82.6x | 1.7x | -84.3x |
| Return on Equity | 917.37 % | industry aggregate | 911.14 % |
| Return on Invested Capital | 1,209.16 % | 1.23 % (avg) | 1,207.93 % |
Source: CSIMarket API, trailing 12 months. A valuation premium or discount is not, by itself, a judgment of over- or under-valuation. Compare it against the return and growth context shown elsewhere on this page.
Cavitation Technologies Inc's Multi-Year Financial Trajectory
Fiscal-year revenue growth, operating margin, return on invested capital and P/E, as reported in SEC filings.| Metric | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue Growth | -36.26 % | 2.41 % | 67.96 % | -58.81 % | 80.33 % | - | - | - |
| Operating Margin | -86.59 % | -51.32 % | 29.54 % | -114.21 % | -32.12 % | - | - | - |
| Return on Invested Capital | 69.76 % | 33.15 % | -55.21 % | -207.96 % | -21.51 % | 66.63 % | -15.69 % | -462.44 % |
| P/E | - | - | - | - | - | - | - | - |
Source: CSIMarket API, fiscal-year figures. P/E is this company's own historical ratio at each fiscal year end and can swing sharply around an earnings trough: that is real, not a data error.
Cavitation Technologies Inc's BCG Growth-Share Matrix
Relative market share (vs Cavitation Technologies Inc's largest competitor by market cap) against industry revenue growth, using the standard textbook thresholds (1.0x share, 10% growth) a common framework, not a precision instrument.
Cavitation Technologies Inc falls in the Dog quadrant: relative market share of 0.00x vs its largest competitor, in an industry growing revenue 4.2% (median, trailing 12 months).
Source: CSIMarket API (market-cap share and industry revenue growth). The 10% growth and 1.0x share lines are standard textbook thresholds, not derived from this industry's own distribution.
Cavitation Technologies Inc's Competitive Forces (Porter's Five Forces)
Only the forces this data can support honestly are shown; the other three are marked as such rather than guessed.| Force | Assessment | Basis |
|---|---|---|
| Competitive Rivalry | Moderate | Industry HHI of 1,570 (see Industry Market Structure & Concentration above) |
| Supplier Power | Not covered on this page | See Cavitation Technologies Inc's dedicated suppliers page for concentration and dependency data |
| Buyer Power | Not covered on this page | See Cavitation Technologies Inc's dedicated customers page for concentration and dependency data |
| Threat of Substitutes | - | No systematic data source for cross-product substitution exists in this system; not estimated |
Note: this is a partial, data-grounded application of the framework, not a complete strategic assessment. Rivalry and barriers-to-entry readings are mechanical translations of the HHI and capital-intensity figures shown elsewhere on this page, not independent judgments.
Cavitation Technologies Inc's Industry Attractiveness & Competitive Strength
A CSIMarket composite, not a standard field: each axis is an equal-weighted average of three factors already shown elsewhere on this page (industry growth, industry profitability and rivalry for attractiveness; relative market share, profitability and growth vs industry for strength). Disclosed as a designed methodology, not a precision measurement.
Cavitation Technologies Inc falls in the Low attractiveness / Low strength cell: Harvest / Divest.
Source: CSIMarket API, trailing 12 months. Each axis score is a simple 1(low)/2(medium)/3(high) average across its three inputs -- a transparent, disclosed simplification, not a validated academic scoring model.
Cavitation Technologies Inc's SWOT
Every point below is a fixed rule applied to a metric already shown elsewhere on this page (Market Structure, Profitability, Valuation, Run-Rate, Stock Performance, Quality Breadth) not an independent strategic assessment. A blank quadrant means no rule was met, not that none apply.Strengths
- Return on equity 911.1 points above the industry aggregate.
Weaknesses
- Latest-quarter revenue run-rate is decelerating (-94.2% annualized vs trailing 12 months).
- Underperforming the U.S.A. 500 over the trailing 12 months.
- Low relative market share vs the industry leader (0.00x).
- Piotroski F-Score of 2 or below, the standard financial-distress signal.
Opportunities
No rule matched.
Threats
No rule matched.
Methodology: mechanical, rule-based SWOT. Each bullet reuses a figure already sourced and cited elsewhere on this page; nothing here is generated narrative or independent analyst judgment.
Cavitation Technologies Inc's Financial Strength vs Peers Comparison
Quick ratio, working capital, debt to equity and asset turnover, trailing 12 months| Company | Quick Ratio | Working Capital | Debt / Equity |
|---|---|---|---|
| Cavitation Technologies Inc | 0.84 | 0.99 | - |
| Originclear Inc | 0.06 | 0.10 | - |
Quick ratio = cash / current liabilities; working capital ratio = current assets / current liabilities; asset turnover = revenue / total assets. Peers in the Blank Checks industry are excluded.
Cavitation Technologies Inc's Revenue and Income Growth vs Peers
Quarterly revenue and net income growth, year over year and quarter over quarter| Company | Period | Revenue Y/Y | Income Y/Y |
|---|---|---|---|
| Cavitation Technologies Inc | Q1 2026 | -97.5 % | - |
| Originclear Inc | Q1 2026 | +9.4 % | - |
| PEERS TOTAL | +2.7 % | - |
Growth is shown only where both periods are positive. Peers in the Blank Checks industry are excluded.
Cavitation Technologies Inc's Peers' Costs of Sales and Capital Expenditures
Context for revenue growth: peer costs and capex, year over year and quarter over quarter| Company | Period | Costs Y/Y | Capex Y/Y |
|---|---|---|---|
| Cavitation Technologies Inc | Q1 2026 | - | - |
| Originclear Inc | Q1 2026 | +56.3 % | - |
Cavitation Technologies Inc's Returns and Turnover vs Peers
ROA, ROI and ROE (trailing 12 months), receivables and inventory turnover| Company | ROA | ROI | ROE |
|---|---|---|---|
| Cavitation Technologies Inc | - | - | - |
| Originclear Inc | - | - | - |
ROA = net income / total assets; ROI = net income / investments; ROE = net income / equity; turnover ratios use trailing 12 month revenue (receivables) and cost of sales (inventory).
Cavitation Technologies Inc's Valuation vs Peers
P/E, price to sales, PEG, price to cash flow and price to book| Company | P/E | Price / Sales |
|---|---|---|
| Cavitation Technologies Inc | - | 62.85 |
| Originclear Inc | - | 1.34 |
| PEERS AVERAGE | - | 3.36 |
P/E = price / diluted EPS (trailing 12 months); PEG = P/E divided by EPS growth; the average row divides the peers' combined market cap by their combined income, sales, cash flow and equity.